Medicskin (08307) has announced its annual results for the year ending March 31, 2024, with revenue of HKD 49.135 million, a year-on-year increase of 7.9%. The company's owners' loss was HKD 3.048 million, a year-on-year narrowing of 13.8%. The basic loss per share was HKD 0.77.

The decrease in losses during the period is mainly due to a follow-up adjustment of employee costs of HKD 700,000 recognized in the comprehensive income statement for the year ending March 31, 2023, while the employee cost related to long-service awards recognized for the year ending March 31, 2024 was HKD 100,000. This adjustment is due to changes in accounting policies related to long-service awards by the Hong Kong Institute of Certified Public Accountants after the announcement of the "Accounting Impact of Cancelling the Mandatory Provident Fund-Long Service Payment Offsetting Mechanism in Hong Kong".